Key Market Indicator:
F&G: 62
25.271,21 NASDAQ · 48.978,00 DOW · 6.884,75 S&P · 4.672,42 Gold · 63,47 BRENT

One Community. One Spirit. N#1 Broker.
all asset classes · all possibilities

Switch View
Hedge the Peak | Protect your Profits
© Globe Newswire
06.06.2025
ISIN: BE0003874915
Fagron NV
FAGR
LISTED
EURONEXT
Fagron increases share capital through exercise subscription rights
Article
News Preview
Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 6 June 2025 – 7PM CET...
Themefolio
Profiler
Peergroup
© PR Newswire
06.06.2025
ISIN: SE0000872095
Swedish Orphan Biovitrum AB (publ)
SOBI
LISTED
STO
Sobi and Apellis: Aspaveli®/Empaveli® Demonstrates Sustained One-Year Efficacy in Phase 3 Study for Rare Kidney Diseases
Article
News Preview
STOCKHOLM, June 6, 2025 /PRNewswire/ -- Sobi® (STO: SOBI) and Apellis Pharmaceuticals, Inc. today presented new data from the open-label period of the Phase 3 VALIANT study, investigating Aspaveli® (pegcetacoplan) for C3 glomerulopathy (C3G) and primary immune complex membranoproliferative glomerulonephritis (IC-MPGN).The data were presented as p...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.06.2025
ISIN: US75629V1044
Recursion Pharmaceuticals Inc
RXRX
LISTED
NASDAQ
MIT and Recursion Release Boltz-2: Next Generation AI Model to Predict Binding Affinity at Unprecedented Speed, Scale, and Accuracy
Article
News Preview
Salt Lake City, UT, June 06, 2025 (GLOBE NEWSWIRE) -- Researchers at the Massachusetts Institute of Technology (MIT) Computer Science and Artificial Intelligence Lab (CSAIL) and Jameel Clinic, alongside TechBio company Recursion (NASDAQ: RXRX), today announced the open-source release of Boltz-2, a first of its kind biomolecular foundation model....
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
More Info
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© Globe Newswire
05.06.2025
ISIN: FR0012127173
OSE Immunotherapeutics SA
OSE
LISTED
EURONEXT
Informations relatives au nombre total de droits de vote et d’actions composant le capital
Article
News Preview
Informations relatives au nombre total de droits de vote et d’actions composant le capital...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© EQS Newswire
05.06.2025
ISIN: DE000A0LD6E6
Gerresheimer AG
GXI
LISTED
XETR
Annual General Meeting approves key proposed resolutions by a large majority
Article
News Preview
Gerresheimer AG: Annual General Meeting approves key proposed resolutions by a large majority 2024: Progress on key strategic topics Long-term outlook remains positve thanks to the successfull transformation into a system and solution provider Dividend of EUR 0.04 per share Duesseldorf, June 5, 2025. The Annual General Meeting of Gerresheimer AG......
Themefolio
Profiler
Peergroup
© EQS Newswire
05.06.2025
ISIN: DE000A0LD6E6
Gerresheimer AG
GXI
LISTED
XETR
Hauptversammlung stimmt mit großer Mehrheit wesentlichen Beschlussvorschläge zu
Article
News Preview
Gerresheimer AG: Hauptversammlung stimmt mit großer Mehrheit wesentlichen Beschlussvorschläge zu 2024: Fortschritte bei wichtigen strategischen Themen Langfristig unverändert positiver Ausblick durch erfolgreiche Transformation zum System- und Lösungsanbieter Dividende von 0,04 EUR je Aktie Düsseldorf, 5. Juni 2025. Die Hauptversammlung der Gerr......
Themefolio
Profiler
Peergroup
© PR Newswire
05.06.2025
ISIN: AU0000165375
Clarity Pharmaceuticals Ltd
CU6
LISTED
ASX
DISCO topline results: 64Cu-SARTATE is highly effective in detecting tumours in NET patients compared to SOC imaging. Phase III planning underway.
Article
News Preview
HIGHLIGHTS Topline data from Clarity's diagnostic Phase II trial, DISCO, confirms that 64Cu-SARTATE is safe and highly effective compared to standard-of-care (SOC) imaging at detecting lesions in patients with neuroendocrine tumours (NETs).DISCO compared the diagnostic performance of 64Cu-SARTATE at an average of 4 hours (between 3 to 5 hours) an...
Themefolio
Profiler
Peergroup
© BusinessWire
05.06.2025
ISIN: GB00BYMT0J19
LivaNova PLC
LIVN
LISTED
NASDAQ
CORE-VNS Study Further Validates Effectiveness of LivaNova’s VNS Therapy on Severe Focal Seizures in Both Children and Adults with Drug-Resistant Epilepsy
Article
News Preview
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced completion of the CORE-VNS study, evaluating comprehensive outcomes of real-world evidence for more than 800 people with epilepsy treated with VNS Therapy™ worldwide. With the clinical study report (CSR) now complete, the final 36-month data further validate...
Themefolio
Profiler
Peergroup
© BusinessWire
05.06.2025
ISIN: GB00BYMT0J19
LivaNova PLC
LIVN
LISTED
NASDAQ
LivaNova Announces CORE-VNS 24-Month Data Show Adjunctive VNS Therapy is Associated with Substantial Reductions in Generalized Tonic-Clonic Seizures in People with Drug-Resistant Epilepsy
Article
News Preview
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced that 24-month data on generalized tonic-clonic (GTC) seizures in people with drug-resistant epilepsy (DRE) from the CORE-VNS three-year study have been published in Epilepsia1. Several CORE-VNS study findings were highlighted in the recent article on GTC se...
Themefolio
Profiler
Peergroup
© BusinessWire
05.06.2025
ISIN: US8292141053
Simulations Plus Inc
SLP
LISTED
NASDAQ
Simulations Plus Releases ADMET Predictor® 13
Article
News Preview
Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today announced the release of ADMET Predictor® 13, its flagship machine learning (ML) modeling platform for the design, op...
Themefolio
Profiler
Peergroup
© BusinessWire
05.06.2025
ISIN: FR0014000MR3
Eurofins Scientific SE
ERF
LISTED
EURONEXT
Eurofins Scientific SE: Director/PDMR Shareholding
Article
News Preview
Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below. This notification is made in accordance with the European Market Abuse Regulation. NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS...
Themefolio
Profiler
Peergroup
© EQS Newswire
05.06.2025
ISIN: DE0005659700
Eckert & Ziegler SE
EUZ
LISTED
XETR
Illuccix® PSMA-PET Imaging Agent Receives Approval in Germany
Article
News Preview
Berlin, Germany, 05 June 2025. Eckert & Ziegler (ISIN DE0005659700, TecDAX) congratulates Telix Pharmaceuticals Limited (Telix) on the approval of its prostate cancer PET imaging agent, Illuccix® (kit for the preparation of gallium-68 gozetotide injection) in Germany, where Eckert & Ziegler Radiopharma GmbH is the official distributor. With......
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© EQS Newswire
05.06.2025
ISIN: DE0005659700
Eckert & Ziegler SE
EUZ
LISTED
XETR
Illuccix® PSMA-PET Diagnostik erhält Zulassung in Deutschland
Article
News Preview
Berlin, Deutschland, 05. Juni 2025. Eckert & Ziegler (ISIN DE0005659700, TecDAX) gratuliert Telix Pharmaceuticals Limited (Telix) zur Zulassung ihres Prostatakrebs-PET-Bildgebungsmittels Illuccix® (Kit zur Herstellung von Gallium-68-Gozetotid-Injektion) in Deutschland, in dem die Eckert & Ziegler Radiopharma GmbH offizieller Vertriebspartne......
Themefolio
Profiler
Peergroup
© PR Newswire
05.06.2025
ISIN: SE0022419784
Sectra AB
SECT_B
LISTED
STO
Sectra's year-end report 2024/2025: Reporting solid growth in a time of change
Article
News Preview
LINKÖPING, Sweden, June 5, 2025 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT B) is continuing to deliver results through high customer satisfaction, innovation and the ongoing transition to service deliveries. With significant advances in medical IT and cybersecurity, growing market shares and innov...
Themefolio
Profiler
Peergroup
© PR Newswire
05.06.2025
ISIN: SE0022419784
Sectra AB
SECT_B
LISTED
STO
Sectra's year-end report 2024/2025: Reporting solid growth in a time of change
Article
News Preview
LINKÖPING, Sweden, June 5, 2025 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT B) is continuing to deliver results through high customer satisfaction, innovation and the ongoing transition to service deliveries. With significant advances in medical IT and cybersecurity, growing market shares and innov...
Themefolio
Profiler
Peergroup
© EQS Newswire
05.06.2025
ISIN: DE000A1EWVY8
Formycon AG
FYB
LISTED
XETR
Lucentis® biosimilar FYB201/Ranivisio® (ranibizumab) approved in Brazil
Article
News Preview
Press Release // June 5, 2025    Lucentis® biosimilar FYB201/Ranivisio® (ranibizumab) approved in Brazil Raniviso® becomes first approved Lucentis® biosimilar in Brazil Commercialization partnership established with Brazilian pharmaceutical company Biomm Product launch in Brazil expected in Q4 2025, kicking off the commercial rollout of FYB201......
Themefolio
Profiler
Peergroup
© EQS Newswire
05.06.2025
ISIN: DE000A1EWVY8
Formycon AG
FYB
LISTED
XETR
Lucentis®-Biosimilar FYB201/Ranivisio® (Ranibizumab) in Brasilien zugelassen
Article
News Preview
Pressemitteilung // 05. Juni 2025   Lucentis®-Biosimilar FYB201/Ranivisio® (Ranibizumab) in Brasilien zugelassen Raniviso® als erstes Lucentis®-Biosimilar in Brasilien zugelassen Kommerzialisierungspartnerschaft mit brasilianischem Pharmaunternehmen Biomm abgeschlossen Produkteinführung in Brasilien ist für das vierte Quartal 2025 geplant und b......
Themefolio
Profiler
Peergroup
© BusinessWire
05.06.2025
ISIN: FR0014000MR3
Eurofins Scientific SE
ERF
LISTED
EURONEXT
Eurofins Consumer Product Testing Announces State-of-the-Art Expansion of Bangalore Laboratory
Article
News Preview
The Eurofins Consumer Product Testing network of laboratories in India recently unveiled its expanded, state-of-the-art facilities in Hongasandra, Bangalore. This strategic investment doubles the Bangalore laboratory’s footprint and offers enhanced capabilities, enabling a significant leap in compliance and performance testing tailored to the evol...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.06.2025
ISIN: FR0010417345
Dbv Technologies SA
DBV
LISTED
EURONEXT
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of May 30, 2025
Article
News Preview
                                                        Information regarding the total number of voting rights and total number of shares of the Company as of May 30, 2025...
Themefolio
Profiler
Peergroup
© ActuNews
04.06.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
OXURION : Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
Article
News Preview
Atlas Special Opportunities, LLC has converted 4 convertible bonds in Oxurion resulting in a EUR 100,000 capital increase. This is part of Atlas Special Opportunities, LLC's EUR 20 million Capital Commitment[1] that will allow Oxurion to focus on developing innovative therapeutics to preserve the vision of elderly people, targeting potential ma...
Themefolio
Profiler
Peergroup
© ActuNews
04.06.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
OXURION : Informatie met betrekking tot het Totaal Aantal Stemrechten (Noemer) volgend op Atlas Conversie-Notificatie
Article
News Preview
Atlas Special Opportunities, LLC heeft 4 converteerbare obligaties in Oxurion geconverteerd resulterende in een kapitaalverhoging van EUR 100.000. Deze conversie vormt deel van Atlas Special Opportunities, LLC's EUR 20 miljoen kapitaaltoezegging1 die aan Oxurion zal toelaten om te focussen op het ontwikkelen van innovatieve geneesmiddelen om he...
Themefolio
Profiler
Peergroup
© ActuNews
04.06.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
Article
News Preview
Leuven, BELGIUM – June 4, 2025 – 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation1 it has received a transparency notification as follows: Oxurion received a transparency notification on June 3, 2025, from Atlas Sp...
Themefolio
Profiler
Peergroup
© ActuNews
04.06.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC
Article
News Preview
Leuven, BELGIË – 4 juni 2025 – 18u00 CET Oxurion NV (Euronext Brussel: OXUR), een biofarmaceutisch bedrijf met hoofdkantoor in Leuven, België, heeft vandaag aangekondigd dat het, in overeenstemming met de Belgische transparantiewetgeving1, de volgende transparantiekennisgeving heeft ontvangen: Oxurion ontving een transparantie...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.06.2025
ISIN: FR0010386334
Clariane SE
CLARI
LISTED
EURONEXT
Renewal of the drawdown under the Revolving Credit Facility for a six-month period
Article
News Preview
Attachment...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.06.2025
ISIN: FR0014008VX5
Euroapi S.A.
EAPI
LISTED
EURONEXT
Frédéric Robert appointed EUROAPI’s Chief Commercial Officer overseeing API Solutions and CDMO activities
Article
News Preview
Paris – June 4, 2025 – EUROAPI, a European leader in the production of active pharmaceutical ingredients (API) and contract development and manufacturing organization (CDMO), is pleased to announce the appointment of Frédéric Robert to the newly created position of Chief Commercial Officer overseeing API Solutions and CDMO activities. He will join...
Themefolio
Profiler
Peergroup
© EQS Newswire
04.06.2025
ISIN: DE000A3ENQ51
SCHOTT Pharma AG & Co KgaA
1SXP
LISTED
XETR
SCHOTT Pharma invests in sterile cartridge production in Hungary
Article
News Preview
SCHOTT Pharma invests in sterile cartridge production in Hungary June 4, 2025, Hungary, Lukácsháza SCHOTT Pharma breaks ground for a new production facility for ready-to-use cartridges in Hungary Its investment of over EUR 100 million is part of the company’s expansion strategy to meet the growing market demand for high-value solutions The new ......
Themefolio
Profiler
Peergroup
© EQS Newswire
04.06.2025
ISIN: DE000A3ENQ51
SCHOTT Pharma AG & Co KgaA
1SXP
LISTED
XETR
SCHOTT Pharma investiert in die Produktion steriler Karpulen in Ungarn
Article
News Preview
SCHOTT Pharma investiert in die Produktion steriler Karpulen in Ungarn 4. Juni 2025, Lukácsháza, Ungarn SCHOTT Pharma beginnt mit dem Bau einer neuen Produktionsstätte für gebrauchsfertige Karpulen in Ungarn Die Investition von über 100 Millionen Euro ist Teil der Expansionsstrategie des Unternehmens, um der wachsenden Nachfrage nach High-Value-......
Themefolio
Profiler
Peergroup
© BusinessWire
04.06.2025
ISIN: GB00BYMT0J19
LivaNova PLC
LIVN
LISTED
NASDAQ
LivaNova Initiates Process with U.S. Centers for Medicare and Medicaid Services for Reconsideration of National Coverage for VNS Therapy for Treatment-Resistant Depression
Article
News Preview
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced it has initiated the process with the U.S. Centers for Medicare and Medicaid Services (CMS) to seek reconsideration of national Medicare coverage for VNS Therapy™ in unipolar patients with treatment-resistant depression (TRD). The first step in the process fo...
Themefolio
Profiler
Peergroup
© PR Newswire
04.06.2025
ISIN: SE0000872095
Swedish Orphan Biovitrum AB (publ)
SOBI
LISTED
STO
Sobi Showcases Breadth of data in C3G/primary IC-MPGN at ERA 2025
Article
News Preview
STOCKHOLM, June 4, 2025 /PRNewswire/ -- Sobi® (STO: SOBI) will have a strong scientific presence at this year's ERA congress in Vienna (4-7 June) with a total of eight presentations: six oral presentations and two posters. We are proud that two of our abstracts have been recognised in the top 10 abstracts at ERA 2025, as selected by expert review...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.06.2025
ISIN: SE0002190926
Karolinska Development AB
KDEV
LISTED
STO
Karolinska Development’s portfolio company OssDsign raises approximately SEK 158 million, announces an updated strategy and revises financial targets
Article
News Preview
STOCKHOLM, SWEDEN, June 4, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that its portfolio company OssDsign has carried out a directed share issue through an accelerated bookbuilding procedure that brought the company approximately SEK 158 million. In connection with the directed share issue, the company announced an updated s...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.06.2025
ISIN: FR0012127173
OSE Immunotherapeutics SA
OSE
LISTED
EURONEXT
Ose Immunotherapeutics : Documents made available to the shareholders for the combined general meeting of June 25th, 2025
Article
News Preview
Documents made available to the shareholders for the combined general meeting of June 25th, 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.06.2025
ISIN: FR0012127173
OSE Immunotherapeutics SA
OSE
LISTED
EURONEXT
OSE Immunotherapeutics strengthens Growth Strategy: Accelerates key pillars of Inflammation and Immuno-Oncology
Article
News Preview
OSE Immunotherapeutics strengthens Growth Strategy: Accelerates key pillars of Inflammation and Immuno-Oncology...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.06.2025
ISIN: BE0003766806
Ion Beam Applications SA
IBAB
LISTED
EURONEXT
World's Leading Institutions and IBA launch Proton Therapy Academy to shape the future of cancer care
Article
News Preview
New global education initiative unveiled at 2025 PTCOG Annual Conference...
Themefolio
Profiler
Peergroup
© BusinessWire
03.06.2025
ISIN: NL0015000DX5
Atai Life Sciences N.V.
ATAI
LISTED
NASDAQ
ATAI Stock Alert: Halper Sadeh LLC is Investigating Whether the Merger of Atai Life Sciences N.V. is Fair to Shareholders
Article
News Preview
Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Atai Life Sciences N.V. (NASDAQ: ATAI) and Beckley Psytech Limited is fair to Atai shareholders. Halper Sadeh encourages Atai shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-00...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.06.2025
ISIN: FI0009014377
Orion Oyj
ORNBV
LISTED
HEL
U.S. FDA approves third indication of darolutamide for patients with advanced prostate cancer
Article
News Preview
ORION CORPORATION PRESS RELEASE 3 JUNE 2025 at 23.30 EEST          ...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.06.2025
ISIN: FR0010417345
Dbv Technologies SA
DBV
LISTED
EURONEXT
DBV Technologies announces the filing of an addendum to the 2024 Universal Registration Document
Article
News Preview
Châtillon, France, June 03, 2025...
Themefolio
Profiler
Peergroup
© PR Newswire
03.06.2025
ISIN: SE0007692850
Camurus AB
CAMX
LISTED
STO
Camurus and Lilly enter collaboration and license agreement for long-acting FluidCrystal® incretins
Article
News Preview
Partnership focused on development of long-acting therapies based on Camurus' FluidCrystal® technology and Eli Lilly's proprietary drug compoundsCamurus eligible to receive up to $870 million in potential development and sales milestone payments and mid-single-digit royaltyLUND, Sweden and INDIANAPOLIS, June 3, 2025 /PRNewswire/ -- Camurus (NASDA...
Themefolio
Profiler
Peergroup
© PR Newswire
03.06.2025
ISIN: SE0007692850
Camurus AB
CAMX
LISTED
STO
Camurus and Lilly enter collaboration and license agreement for long-acting FluidCrystal® incretins
Article
News Preview
Partnership focused on development of long-acting therapies based on Camurus' FluidCrystal® technology and Eli Lilly's proprietary drug compoundsCamurus eligible to receive up to $870 million in potential development and sales milestone payments and mid-single-digit royaltyLUND, Sweden and INDIANAPOLIS, June 3, 2025 /PRNewswire/ -- Camurus (NASDA...
Themefolio
Profiler
Peergroup
© EQS Newswire
03.06.2025
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Ergebnisse der Hauptversammlung 2025
Article
News Preview
Alle Tagesordnungspunkte angenommen Unter dem Motto „Pioneering Drug Discovery – Wegweisende Arzneimittelforschung“ stellte CEO Dr. Christian Wojczewski die aktuelle Situation und den strategischen Ausblick von Evotec vor 46,45 % des eingetragenen Grundkapitals vertreten Hamburg, 03. Juni 2025: Evotec SE (Frankfurter Wertpapierbörse: EVT, MDAX/Te......
Themefolio
Profiler
Peergroup
© EQS Newswire
03.06.2025
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Results of the Annual General Meeting 2025
Article
News Preview
All agenda items adopted Under the topic “Pioneering Drug Discovery” CEO Dr Christian Wojczewski presented Evotec’s current situation and strategic outlook 46.45% of the registered share capital represented Hamburg, Germany, 03 June 2025: Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) today announced that ......
Themefolio
Profiler
Peergroup
© Globe Newswire
03.06.2025
ISIN: US52490G1022
Legend Biotech Corp
LEGN
LISTED
NASDAQ
Legend Biotech Unveils Groundbreaking 5-Year Survival Data for CARVYKTI® in Multiple Myeloma at 2025 ASCO Annual Meeting
Article
News Preview
SOMERSET, N.J., June 03, 2025 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, announced today new long-term results from the CARTITUDE-1 study in heavily pretreated relapsed/refractory multiple myeloma (RRMM) patients. RRMM patients were treated with a single infusion of CARVYKTI® (...
Themefolio
Profiler
Peergroup
© EQS Newswire
03.06.2025
ISIN: FR0004056851
Valneva SE
VLA
LISTED
EURONEXT
First Berlin Equity Research GmbH: Valneva SE | Rating: Buy
Article
News Preview
Original-Research: Valneva SE - von First Berlin Equity Research GmbH 03.06.2025 / 14:27 CET/CEST Veröffentlichung einer Research, übermittelt durch EQS News - ein Service der EQS Group. Für den Inhalt der Mitteilung bzw. Research ist alleine der Herausgeber bzw. Ersteller der Studie verantwortlich. Diese Meldung ist keine Anlageberatung oder Au......
Themefolio
Profiler
Peergroup
© BusinessWire
03.06.2025
ISIN: CA23256X4075
Cybin Inc.
HELP
LISTED
NASDAQ
Cybin Announces Additional U.S. Patent Supporting its CYB004 Program in Phase 2 Development for Generalized Anxiety Disorder
Article
News Preview
Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options, today announced that the United States Patent and Trademark Office has granted U.S. patent 12,318,477 in...
Themefolio
Profiler
Peergroup
© PR Newswire
03.06.2025
ISIN: SE0000872095
Swedish Orphan Biovitrum AB (publ)
SOBI
LISTED
STO
Invitation: Sobi's Aspaveli® - 52-week Phase 3 VALIANT data in nephrology
Article
News Preview
VALIANT Phase 3 data in nephrology after presentation at the ERA congress. STOCKHOLM, June 3, 2025 /PRNewswire/ -- Investors, analysts, and members of the media are invited to a conference call on Thursday, 12 June, at 13:30 CEST, 12:30 GMT, and 08:30 EDT. The call will include a presentation of results and insights from management and Professor...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.06.2025
ISIN: GB00BDFBVT43
Oxford Biomedica PLC
OXB
LISTED
LSE
OXB Highlights the Launch of its Innovation and Technology Excellence Board
Article
News Preview
...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.06.2025
ISIN: US68232V8019
Traws Pharma Inc.
TRAW
LISTED
NASDAQ
Traws Pharma Announces Publication of Compelling Efficacy data in RDEB SCC Patients Treated with Legacy Oncology Drug Rigosertib
Article
News Preview
NEWTOWN, Pa., June 03, 2025 (GLOBE NEWSWIRE) -- Traws Pharma, Inc. (NASDAQ: TRAW) (“Traws Pharma”, “Traws” or “the Company”), a clinical-stage biopharmaceutical company developing novel therapies to target critical threats to human health from respiratory viral diseases, today announced the publication of key clinical efficacy data for rigosertib...
Themefolio
Profiler
Peergroup
© PR Newswire
03.06.2025
ISIN: ES0169501022
Pharma Mar SA
PHM
LISTED
BME
PharmaMar präsentiert auf der ASCO dass Zepzelca® (lurbinectedin) in Kombination mit Atezolizumab (Tecentriq®) das Überleben als Erstlinien-Erhaltungstherapie bei kleinzelligem Lungenkrebs
Article
News Preview
Die Erstlinien-Erhaltungskombinationstherapie verringerte das Risiko eines Fortschreitens der Krankheit oder des Todes um 46%, mit einer medianen Gesamtüberlebenszeit von 13,2 Monaten gegenüber der 10,6 Monaten für Atezolizumab allein, ab dem Zeitpunkt der RandomisierungErste Phase-3-Studie, die statistisch signifikante und klinisch bedeutsame Ve...
Themefolio
Profiler
Peergroup
© PR Newswire
03.06.2025
ISIN: ES0169501022
Pharma Mar SA
PHM
LISTED
BME
PharmaMar presents at ASCO that the Zepzelca®(lurbinectedin) and atezolizumab (Tecentriq®) combination significantly improves survival as first-line maintenance therapy for extensive-stage small cell lung cancer
Article
News Preview
First-line maintenance combination therapy reduced the risk of disease progression or death by 46%, with a median overall survival of 13.2 months vs 10.6 months for atezolizumab alone from the point of randomizationFirst Phase 3 study to demonstrate statistically significant and clinically meaningful improvements in both progression-free and over...
Themefolio
Profiler
Peergroup
© PR Newswire
02.06.2025
ISIN: NL0012169213
Qiagen NV
QGEN
LISTED
NYSE
Foresight Diagnostics and QIAGEN Announce Strategic Partnership to Advance Development of Companion Diagnostic Kits for Lymphoma
Article
News Preview
BOULDER, Colo., Jun 2, 2025 /PRNewswire/ -- Foresight Diagnostics, a leading diagnostics company specializing in ultra-sensitive minimal residual disease (MRD) detection, today announced a strategic, worldwide partnership with QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) to develop and commercialize a kit-based version of Foresight's CLARIT...
Themefolio
Profiler
Peergroup
© BusinessWire
02.06.2025
ISIN: IE0005711209
ICON PLC
ICLR
LISTED
NASDAQ
ICLR Investors Have Opportunity to Lead ICON Public Limited Company Securities Fraud Lawsuit with the Schall Law Firm
Article
News Preview
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ICON Public Limited Company (“ICON” or “the Company”) (NASDAQ: ICLR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission....
Themefolio
Profiler
Peergroup
© Globe Newswire
02.06.2025
ISIN: DK0010272202
Genmab A/S
GMAB
LISTED
CPH
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial
Article
News Preview
Media ReleaseCOPENHAGEN, Denmark; June 2, 2025...
Themefolio
Profiler
Peergroup
© PR Newswire
02.06.2025
ISIN: SE0000736415
Orexo AB
ORX
LISTED
STO
Orexo to present clinical data for OX640 at the EAACI Congress
Article
News Preview
OX640 is a nasal rescue medication with powder-based epinephrine for the treatment of severe allergic reactions (including anaphylaxis) and is based on the proprietary AmorphOX® technologyEAACI is a leading global association devoted to allergic and immunology diseasesOrexo´s advisor Dr. Anne K Ellis, Professor and Chair of the Division of Allerg...
Themefolio
Profiler
Peergroup
© PR Newswire
02.06.2025
ISIN: SE0000736415
Orexo AB
ORX
LISTED
STO
Orexo to present clinical data for OX640 at the EAACI Congress
Article
News Preview
OX640 is a nasal rescue medication with powder-based epinephrine for the treatment of severe allergic reactions (including anaphylaxis) and is based on the proprietary AmorphOX® technologyEAACI is a leading global association devoted to allergic and immunology diseasesOrexo´s advisor Dr. Anne K Ellis, Professor and Chair of the Division of Allerg...
Themefolio
Profiler
Peergroup
© BusinessWire
02.06.2025
ISIN: US09609G2093
bluebird bio, Inc.
BLUE
LISTED
NASDAQ
bluebird bio Announces Completion of Acquisition by Carlyle and SK Capital
Article
News Preview
bluebird bio (NASDAQ: BLUE) (“bluebird”), a pioneer in gene therapies for severe genetic diseases, today announced the completion of its sale to funds managed by global investment firms Carlyle (NASDAQ: CG) and SK Capital Partners, LP (“SK Capital”). With the closing of the transaction, bluebird’s common stock has ceased trading and will no longer...
Themefolio
Profiler
Peergroup
© BusinessWire
02.06.2025
ISIN: US88023B1035
Tempus AI, Inc.
TEM
LISTED
NASDAQ
Tempus Introduces xM, An Assay to Monitor Immunotherapy Response for Patients with Advanced Cancers
Article
News Preview
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced xM for treatment response monitoring (TRM), a liquid biopsy assay intended to detect molecular response to immune-checkpoint inhibitor (ICI) therapy in advanced solid tumors. xM for TRM is the newest additi...
Themefolio
Profiler
Peergroup
© BusinessWire
02.06.2025
ISIN: FR0014000MR3
Eurofins Scientific SE
ERF
LISTED
EURONEXT
Eurofins Scientific SE: Director/PDMR Shareholding
Article
News Preview
Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below. This notification is made in accordance with the European Market Abuse Regulation. NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS...
Themefolio
Profiler
Peergroup
© PR Newswire
02.06.2025
ISIN: SE0000135485
RaySearch Laboratories AB (publ)
RAY B
LISTED
STO
RaySearch to present advanced software innovations for particle therapy at PTCOG 63
Article
News Preview
STOCKHOLM, June 2, 2025 /PRNewswire/ -- RaySearch Laboratories AB (publ) will exhibit at PTCOG 63, held June 3-6, 2025, in Buenos Aires, Argentina. At booth #08, the company will showcase its latest software innovations driving the future of particle therapy. RaySearch's portfolio – including RayStation®*, RayCare®*, RayIntelligence®, and RayCom...
Themefolio
Profiler
Peergroup
© BusinessWire
02.06.2025
ISIN: US98887Q1040
Zai Lab Limited
ZLAB
LISTED
NASDAQ
Zai Lab Presents Positive Phase 1 Data for ZL-1310, a DLL3-Targeted ADC, Demonstrating Robust Anti-Tumor Activity and Safety in Patients with Extensive-Stage Small Cell Lung Cancer at 2025 ASCO Annual Meeting
Article
News Preview
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that updated data from an ongoing, global Phase 1a/1b clinical trial (NCT06179069) evaluating zocilurtatug pelitecan, or ZL-1310, the Company’s potential first-in-class, Delta-like ligand (DLL3) antibody-drug conjugate (ADC) for patients with extensive-stage small cell lung cancer (ES-SCLC...
Themefolio
Profiler
Peergroup
© EQS Newswire
02.06.2025
ISIN: DE000A0LD6E6
Gerresheimer AG
GXI
LISTED
XETR
Gerresheimer Adjusts Guidance for Financial Year 2025
Article
News Preview
Gerresheimer Adjusts Guidance for Financial Year 2025 Preliminary results for Q2 2025: Low-single-digit organic revenue growth, adjusted EBITDA margin around 19% Continued subdued demand in the cosmetics market Temporary decline in demand for containment solutions for oral liquid medications New dividend proposal of 4% of share capital Long-te......
Themefolio
Profiler
Peergroup
© EQS Newswire
02.06.2025
ISIN: DE000A0LD6E6
Gerresheimer AG
GXI
LISTED
XETR
Gerresheimer passt Prognose für das Geschäftsjahr 2025 an
Article
News Preview
Gerresheimer passt Prognose für das Geschäftsjahr 2025 an Vorläufiges Ergebnis Q2 2025: Organisches Umsatzwachstum im niedrigen einstelligen Prozentbereich, Adjusted EBITDA-Marge um 19 % Weiterhin gedämpfte Nachfrage im Kosmetikmarkt Temporärer Nachfragerückgang bei Containment-Lösungen für oral einzunehmende flüssige Medikamente Neuer Dividend......
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
Indices
DAX, DOW, S&P, FTSE...
Realtime Trading
With & without leverage
Currencies
EUR, USD, JPY, BRL, GBP ....
50 FX-Pairs
Top Conditions, Tied spreads, Mini/Micro
Commodities
Brent, WTI, Coffee, Wheat....
Long & Short
Crude oil, Agricultural & more
Metals
Gold, Silver, Palladium, Platinum
Hedging
Soft-,Heavy-, Precious Metals
Stocks & ETF
TSLA, NFLX, NVDA, MSFT, AAPL ....
Leveraged Equity Trading
USA, Europe, Asia
More information, click here

More sector specific news

Your Press Release is missing or you want share news over GICS11? Drop us a line.

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

XLB
XLE
XLU
XLY
XLF
XLP
XLV
XLK
XLC
XLI
XLRE
© 2026 Select Sector SPDRs
* * *
More Sector related Investment Ideas
XLB
XLE
XLU
XLY
XLF
XLP
XLV
XLK
XLC
XLI
XLRE
© 2026 WEBs Investments ETFs
About the newsfeed
#1
What types of information are provided on this portal - and what purpose does it serve?
The portal provides structured, stock market-relevant company information that is specifically assigned to a particular economic sector. The focus is on current announcements from official NewsWire sources, supplemented by company profiles, filter options by sector and sector-specific research aids. The aim is to offer an interested group of people a systematically structured research environment that improves their understanding of sector developments and corporate strategies.
#2
Why are companies categorized according to a certain system?
Financial markets consist of thousands of listed companies with very different business models. In order to create transparency and comparability, companies worldwide are assigned to standardized classifications. These classifications help investors to better analyze markets, identify sector-specific trends and make more targeted investment decisions.
#3
What classification standards exist for grouping companies?
There are various industry classifications that are used depending on the region or application. The best known include GICS (Global Industry Classification Standard), ICB (Industry Classification Benchmark), NAICS (North American Industry Classification System) and TRBC (Thomson Reuters Business Classification). Most institutional investors and ETFs worldwide use GICS or ICB as a benchmark.
#4
What classification standard is this financial information portal based on?
The portal uses the Global Industry Classification Standard (GICS), which was jointly developed by MSCI and S&P Dow Jones Indices. GICS is widely used in the institutional financial world and forms the basis for many global equity indices, ETFs and research systems.
#5
What exactly does GICS mean - and how is the system structured?
GICS stands for Global Industry Classification Standard. It is a hierarchical structure that divides listed companies worldwide into four levels: Sector, Industry Group, Industry Sector and Sub-Industry. In total, the system comprises 11 main sectors, over 60 industries and more than 150 sub-categories. It allows a consistent, internationally comparable analysis of economic activities.
#6
Why is GICS important in the financial world?
GICS offers a standardized language for investment decisions. It makes it possible to compare companies with similar business models - regardless of country, stock exchange or company size. Many investment funds, indices and research houses use GICS as a basis for portfolio construction, risk analysis or market screening. This means that it also makes sense for private investors to use this structure as a guide.
#7
Who decides which GICS sector a company is assigned to?
The allocation is made by the index providers MSCI and S&P Dow Jones on the basis of a company's main business segment. The decisive factor is the segment from which the company generates the majority of its sales or operating profit. Changes in the business model or strategic realignments can lead to a company being assigned to a different industry or even a different sector.
#8
What is meant by the GICS sector "Materials"?

The GICS "Materials" sector comprises companies that are active in the production, processing or refinement of raw materials. This includes industries such as chemicals, building materials, paper & forest products and the entire metallurgical and mining industry. The sector is highly cyclical and is particularly sensitive to economic fluctuations and changes in global demand.

#9
Which companies typically belong to the Materials sector?
Typical representatives are international groups from the areas of chemicals production (e.g. BASF), precious metal mining (e.g. Barrick Gold), building materials production (e.g. Heidelberg Materials) or industrial gases (e.g. Linde). The shares of these companies are often heavily dependent on commodity prices and play a central role in industrial value chains.
#10
Where does the company news on this page come from?
The news is based on verified and publicly available sources such as BusinessWire, GlobeNewswire, PR Newswire, EQS, Newsfile, ACCESSNewswire and other NewsWire services. These platforms are used by listed companies to publish mandatory ad hoc announcements, financial reports or strategic developments. All content is prepared in a structured manner and, if a corresponding categorization is possible, brought together in industry-specific clusters.
#11
How is the sector-specific mapping of messages carried out?
Categorization is based on structured metadata (e.g. ISIN, ticker, sector classification) and a combination of keyword analysis and GICS mapping. This ensures that all news is assigned to the correct sector and - if available - the correct sub-sector.
#12
Why is the materials sector particularly interesting for investors?
The Materials sector is closely linked to global industrial production and offers both cyclical growth opportunities and hedging opportunities against inflation and raw material shortages. In addition, many companies in this sector play a key role in future topics such as electromobility, the energy transition and sustainable building materials.
#13
What distinguishes this project from traditional financial information portals?
In contrast to generic portals, this project focuses exclusively and specifically on a particular sector. The advantage for interested investors: Sector-specific information, news, market movements and company profiles can be filtered and analyzed in a more targeted manner. This enables more in-depth research and greater relevance for thematic investment decisions.
#14
Are smaller companies also represented here or only large corporations?
The newsfeed takes into account both large caps and mid and small caps. As a clear mapping criterion is required in order to enable the most precise possible allocation to a cluster, the ISIN of the listed company is generally used for this purpose, provided that this can be made available or mapped via corresponding newsfeed parameters.
#15
How up-to-date are the displayed messages?
The content is updated regularly. The publication follows the publications of the information source, the NewsWire feeds of the underlying distributors. Incoming reports are automatically processed, classified and displayed on the page. Timestamps and source information ensure maximum transparency.
#16
Can I also filter the news by sub-sector?
Yes, this is a central feature of the site. Within a main sector, you can filter specifically for sub-sectors such as "Metals & Mining". For particularly popular industries or developments within a meta-sector, it is possible to deviate from standard clusters. Special categories with particular information value enable thematic analyses to be carried out even more precisely.
#17
Are there plans to process other metasectors in a similar way?
Yes, this financial information portal is part of an extensive project in which separate information portals are being created for all the main sectors. The aim is to provide investors with a systematic, sector-based research tool - regardless of index affiliation or provider perspective.
#18
Why do companies publish announcements via NewsWire services at all?
NewsWire services such as BusinessWire or PR Newswire fulfill a regulatory function: they enable companies to publish price-sensitive information publicly and without discrimination. In many countries, the use of such services is a prerequisite for fulfilling publication obligations under capital market law. They also enable companies to reach the media, analysts and investors in a targeted manner.
#19
Can private or inactive companies also appear in such notifications?
Generally not. The platform focuses exclusively on listed companies whose disclosures are based on regulatory requirements or corporate strategy measures. Although private or unlisted companies occasionally publish announcements, these are not systematically processed or classified here.
#20
What happens when a company changes its business model - does its sector classification also change?
Yes, as a rule - but not automatically. The responsible classification institutes (e.g. MSCI and S&P for GICS) regularly check the relevance and consistency of the classifications. If there is a significant change in a company's sales or profit profile, it may be reclassified to a different industry or even a different sector. This usually takes place after fixed review cycles or upon request.
#21
How is it ensured that a company is correctly categorized if it is active in several business areas?
The categorization is based on the dominant sales segment. If a company is active in several sectors but generates 70% of its turnover with chemical products, for example, it is assigned to the GICS sector "Materials" - even if it also has activities in the energy or transportation sector. In borderline cases, additional qualitative assessment criteria apply.
#22
Are there any legal risks in the further use of the displayed content?
The content comes from public sources, but is partially subject to copyright protection - particularly with regard to text structure and layout. The excerpts and links provided on this portal are made within the scope of permitted use (e.g. right to quote or editorial processing). However, commercial use by third parties is not permitted without the express permission of the original providers.
#23
Who can I contact if I have general questions or legal concerns?
A central contact point is available for general inquiries, information on company recordings, compliance issues or copyright-relevant aspects. In rare cases, for example in the case of erroneously published information or justified requests for deletion, a review and, if necessary, removal from the public feed can take place. Please only use the official contact option in the legal notice or at the bottom of the page.
#24
Is advertising or third-party content also displayed on the portal?
Yes, in defined areas the portal can display advertising content or product-specific information from third parties - for example on sector-related financial services, research offers or trading platforms. This content is clearly marked as advertising or partner information and is separate from the editorial or automatically processed company news.
#26
Can I give feedback on the platform or submit suggestions?
Absolutely - feedback is expressly welcome. The platform is an open information service that is continuously being developed. Comments on functionality, data quality, usability or thematic extensions help to optimize the service for the benefit of users. You can submit your suggestions informally via the contact page or special feedback forms.
#27
I am an information provider - can I cooperate with the portal?
Yes, the portal is open to content-related, technical or editorial cooperation, provided that this contributes to the quality, relevance or dissemination of the offering. If you offer content, interfaces or services that could be useful in the context of stock market-related information, we would be pleased to hear from you. The platform offers flexible integration options and a professional environment for quality-assured content.
#28
Can the platform technology also be used for other applications or partners?
Yes, the platform is based on a modular, scalable infrastructure that can be adapted to different information contexts and industry models. Technical components such as data aggregation, structuring logic, classification mechanisms and semantic filters can also be made available for external projects or individual applications on request. Please contact us for cooperation or license models.
#29
Can the underlying company data also be licensed or reused?
Structured access to selected master data of listed companies - such as GICS mapping, ISIN mapping, news feeds or metadata filters - is generally possible. The offer is aimed in particular at information service providers, research platforms or data-driven financial applications. Data can be provided via defined interfaces (e.g. API) or exportable formats, depending on the intended use and license framework.
#30
What forms of cooperation with external partners are conceivable?
Basically open. Possible forms of cooperation range from technical integrations and shared data models to content syndication or white label solutions. Partnerships with institutions that are looking for access to quality-assured data, dynamically structured news or sector-specific analyses - for example in the FinTech, media or research environment - are particularly interesting. We look forward to hearing from business development or product management departments.
#31
Why does this portal differ technically and conceptually from other information offerings?
Because no one from outside the industry is trying to understand the financial market here - but because the know-how comes from the heart of the financial world. The technical platform was developed by a team that combines in-depth market knowledge with innovative system design. The result: information architecture with real relevance, not shop window technology.
#32
What makes the technical solution particularly interesting for operators of their own financial portals?
In addition to high adaptability, the platform impresses with its modular structure and the consistent implementation of industry-specific logic - from GICS mapping to metadata filtering. For providers who operate their own information portals, sector-specific data structures, news feeds or visualizations can be quickly integrated on this basis - either as a white label, API module or embedded solution.
#33
Why can a collaboration go beyond traditional development services?
Because we don't just program, we think: The technological implementation is based on a deep understanding of market cycles, regulations, data formats and investor needs. Anyone who cooperates with this platform benefits from a sparring partner at eye level - both technically and professionally. This creates added value that goes far beyond pure IT expertise.
#34
Note on copyright and the processing of original content
The corporate news presented on this information portal is based on publicly accessible sources such as BusinessWire, GlobeNewswire, PR Newswire or comparable news services. The content is processed as part of an automated or editorially supported structuring process without changing, shortening or reinterpreting the content of the original information. This is so-called "as is" information, the form and content of which corresponds to the originally published announcement. The rights to the original texts remain unrestrictedly with the respective publishers or copyright holders. This portal merely assumes a structural categorization and allocation within the framework of a news-journalistic offer. Independent commercial reuse, systematic reproduction or other use of the content by third parties is only permitted within the framework of the statutory provisions or with the consent of the copyright holder.
About GICS Health
GICS Health is part of the GICS Eleven information portfolio, which focuses primarily on information from listed companies in the health sector. The sector classification serves as a guide to navigate quickly and conveniently through the latest industry-specific news. Individual peer group clusters complement the news offering.
About GICS Eleven

GICS Eleven (G11, GICS11) bundles topic-specific content and enables quick access to relevant information thanks to its gate function. The project is largely based on the Global Industry Classification Standard (GICS®), which was developed by MSCI and Standard & Poor's and enables a breakdown into sectors. GICS® consists of 11 sectors, 24 industry branches, 69 industries and 158 sub-industries.

GICS® is a registered trademark of MSCI Inc. and S&P Dow Jones Indices.

Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Monday, 19.01.2026, Calendar Week 04, 19th day of the year, 346 days remaining until EoY.